In this interview, discover how Charles River uses the power of microdialysis for drug development as
well as CNS therapeutics.
well as CNS therapeutics.
Anavex Life Sciences is in a tough spot. The serial dissembler of clinical trial results might be forced, finally, to tell the truth when it
Altesa BioSciences has raised a $35 million Series A from undisclosed investors, according to an SEC filing from July. The company develops antiviral drugs for